Latest filing published 23 Jun 2026 for Agios Pharmaceuticals, INC.. Read the official filing
No signal scores available.
Filings by Adams Catherine Owen span 2 companies, the busiest being Agios Pharmaceuticals, Inc. and Acadia Pharmaceuticals Inc. Over a trading history stretching from 13 June 2025 to 18 June 2026, the count stands at 5 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 23 June 2026, reports an option exercise in Agios Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations